Intercos (BIT:ICOS)
Historical Stock Chart
From May 2019 to May 2024
Cialis(R) (tadalafil) Joins BASS as Premiere Sponsor
-- Multi-Faceted Sponsorship Includes Unique Elements --
KISSIMMEE, Fla., Jan. 24 /PRNewswire-FirstCall/ -- Cialis(R) (tadalafil), the
erectile dysfunction drug marketed by Lilly ICOS
(NYSE:LLYNYSE:andNYSE:Nasdaq:NYSE:ICOS), and BASS, the worldwide authority on
bass fishing, today announced a one-year sponsorship agreement. As a premiere
sponsor, Cialis will have a major interactive presence at the majority of BASS
events, including the CITGO Bassmaster Tournament Trail, the Bassmaster Elite
50 Series and the CITGO Bassmaster Classic.
The agreement also includes presenting sponsorship of Bassmaster University and
a heavy presence in BASS's television, print and internet platforms. To
support the sponsorship, Cialis will create Relaxation and Fan Experience tents
in key markets, develop angler tips with expert partners and establish a
dedicated Web site. To enhance the Bassmaster University TV show on ESPN2,
Cialis will sponsor a "gear list" as part of the weekly programming, which will
highlight fishing equipment needed for each episode.
"Lilly ICOS is thrilled to be a premiere sponsor of BASS through our Cialis
brand," said Matt Beebe, Cialis U.S. Brand Team Leader. "BASS members are an
important audience to us. An alliance with BASS allows us to reach a targeted
fan base that enjoys bass fishing because it's both relaxing and exhilarating."
Don Rucks, General Manager of BASS, said: "We are pleased Cialis chose to make
BASS part of their marketing program. We applaud the vision of Lilly ICOS in
recognizing the significance of the brand-loyal BASS members and fans."
Cialis and BASS have worked closely together to develop an integrated platform
that will resonate with members and fans and help enhance relaxation and
enjoyment of the sport.
* Signage: Beginning at the season-opener on Lake Tohopekaliga in Kissimmee,
Cialis will have a strong signage presence at a total of 108 BASS events. This
includes boat, truck and driver uniform signage during 12 televised events.
* Bassmaster University: Cialis is the presenting sponsor of Bassmaster
University for the entire 2005 season. This includes opening and closing
credits on each episode as well as a weekly "gear list" sponsored by Cialis
that highlights fishing equipment needed for each lesson. An online Bassmaster
University page will link to http://www.cialis.com/ . Bassmaster University
airs on BASS Saturday at 9:30 a.m. ET on ESPN2.
* Exhibition Tent: Spectators at select BASS events can experience the
"Bassmaster University presented by Cialis" tent, which will be stocked with
angler-related interactive elements and seminars with expert anglers.
Highlights from ESPN2's Bassmaster University will also be featured in the
Cialis tent.
* Relaxation Centers: Key viewing spots at the Bassmaster Elite 50, CITGO
Bassmaster Tour and CITGO Bassmaster Classic will be branded "Relaxation
Centers presented by Cialis." The relaxing atmosphere will be designed to help
spectators unwind and enjoy the spectacular views of the weigh-in.
* Tips Booklet: A Cialis-sponsored tips booklet for fishing and men's health
will be available at all 108 tournaments in which Cialis will have a presence.
* Interactive Web Site: Angling fans everywhere can soon visit
http://www.bassmaster.com/ to experience many of the innovative elements of the
Cialis BASS sponsorship, including tips for relaxing and improving their
fishing skills.
Cialis BASS Sponsorship
For Lilly ICOS, the BASS sponsorship represents a unique opportunity to educate
men in the United States about a significant health issue -- erectile
dysfunction (ED) -- and the role of Cialis as the only oral ED treatment option
shown to improve erectile function for up to 36 hours in most men. Through its
partnership with BASS, Lilly ICOS offers consumers information about ED and
Cialis. Consumers may pick up brochures on ED or Cialis at the tents, and
visit the Cialis Web site, http://www.cialis.com/ , to get more information
about Cialis. Available by prescription, Cialis was approved by the U.S. Food
& Drug Administration on November 21, 2003.
About BASS
BASS is the world's largest fishing organization, sanctioning more than 20,000
tournaments worldwide through its Federation. The CITGO Bassmaster Tournament
Trail, which includes the exciting Bassmaster Elite 50 series, is the oldest
and most prestigious pro bass fishing tournament circuit and continues to set
the standard for credibility, professionalism and sportsmanship as it has since
1968. For more information, contact BASS Communications at (334) 551-2375 or
visit http://www.bassmaster.com/ .
About Cialis
Cialis, approved by the FDA in November 2003 for the treatment of erectile
dysfunction, is the only oral ED treatment shown to improve erectile function
up to 36 hours in most men. Cialis can be taken without regard to food. The
absorption of Cialis is not reduced by food, including high-fat foods. Cialis
is currently available in approximately 100 countries, including Australia,
Brazil, Mexico, Canada, the United States and countries throughout Europe. More
than 3.5 million patients worldwide have been treated with Cialis since its
first introduction in February 2003.
Cialis is available by prescription only and is not for everyone. Men taking
nitrates, often used for chest pain, or certain alpha-blockers for prostate
problems or high blood pressure, should not take Cialis. Such combinations
could cause a sudden, unsafe drop in blood pressure.
Men should discuss their health status with their doctors to ensure Cialis is
right for them and that they are healthy enough for sexual activity. The most
common side effects with Cialis were headache, upset stomach, delayed backache
or muscle ache. Although rare, men who experience an erection for more than
four hours should seek immediate medical attention. Men should not drink
alcohol in excess with Cialis. Cialis does not protect a man or his partner
from sexually transmitted diseases, including HIV.
Individual results may vary. Cialis studies were not designed to assess
multiple intercourse attempts after a single dose. For full patient
information, visit http://www.cialis.com/ .
About Lilly ICOS LLC
Lilly ICOS LLC, a joint venture between ICOS Corporation (NASDAQ:ICOS) and Eli
Lilly and Company (NYSE:LLY), developed tadalafil for the treatment of erectile
dysfunction.
ICOS Corporation, a biotechnology company headquartered in Bothell, Washington,
is dedicated to bringing innovative therapeutics to patients. ICOS is marketing
its first product, Cialis (tadalafil), through Lilly ICOS LLC. ICOS is working
to develop treatments for serious unmet medical conditions such as chronic
obstructive pulmonary disease, benign prostatic hyperplasia, cancer and
inflammatory diseases.
Lilly, a leading innovation-driven corporation is developing a growing
portfolio of first-in-class and best-in-class pharmaceutical products by
applying the latest research from its own worldwide laboratories and from
collaborations with eminent scientific organizations. Headquartered in
Indianapolis, Ind., Lilly provides answers -- through medicines and information
-- for some of the world's most urgent medical needs. Additional information
about Lilly is available at http://www.lilly.com/ . P-LLY
Except for historical information contained herein, this press release contains
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements are based on
current expectations, estimates and projections about the industry, management
beliefs and certain assumptions made by the management of ICOS and Lilly.
Investors are cautioned that matters subject to forward-looking statements
involve risks and uncertainties, including economic, competitive, governmental,
technological, legal and other factors discussed in the two companies'
respective filings with the Securities and Exchange Commission, which may
affect the business and prospects of the two companies and Lilly ICOS. Results
and the timing and outcome of events may differ materially from those expressed
or implied by the forward-looking statements in this press release. More
specifically, there can be no assurance that Cialis will achieve commercial
success or that competing products will not pre-empt market opportunities that
might exist for the product.
Cialis(R) is a registered trademark of Lilly ICOS LLC. Other trademarks are
the property of their respective owners.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040122/LILLYICOSLOGO
http://www.newscom.com/cgi-bin/prnh/20050124/BASSLOGO
http://www.newscom.com/cgi-bin/prnh/20050124/CIALISLOGO)
http://www.newscom.com/cgi-bin/prnh/20040122/LILLYICOSLOGO
http://www.newscom.com/cgi-bin/prnh/20050124/BASSLOGO
http://www.newscom.com/cgi-bin/prnh/20050124/CIALISLOGO
DATASOURCE: Lilly ICOS LLC
CONTACT: Kindra Strupp of Cialis, +1-317-277-5170; or Jamie Wilkinson of
BASS, +1-334-551-2457
Web site: http://www.cialis.com/
http://www.bassmaster.com/
http://www.lilly.com/